Health Care Utilization of People with Alcohol Dependence;Inanspruchnahme gesundheitlicher Versorgung durch Alkoholabhängige

Suchttherapie

Volumn 16, Issue 1, 2015, Pages 18-26

  Kraus, L ^a,b   Piontek, D ^a   Pfeiffer Gerschel, T ^a   Rehm, J ^c,d,e,f  

^a IFT INSTITUT FÜR THERAPIEFORSCHUNG   (Germany)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

addiction care; alcohol dependence; health care; utilization

Indexed keywords

EID: 84905874442     PISSN: 14399903     EISSN: 1439989X     Source Type: Journal    
DOI: 10.1055/s-0034-1376999     Document Type: Article

References (47)

1. American Psychiatric Association DSM-IV Diagnostic and statistical manual of mental disorders. Washington, DC American Psychiatric Association: 1994
2. Wittchen H. U., Jacobi F., Rehm J. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol: 2011; 21 655 679
3. Pabst A., Kraus L., Gomes de Matos E. et al. Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012. Sucht: 2013; 59 321 331 Open Access http://www.psycontent.com/content/946m87w0g4812vu8/fulltext.pdf
4. Schomerus G., Holzinger A., Matschinger H. et al. Einstellung der Bevölkerung zu Alkoholkranken. Psychiatr Prax: 2010; 37 111 118
5. Rehm J., Dawson D., Frick U. et al. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res: 2014
6. Rehm J., Shield K. D., Rehm M. X. et al. Alcohol consumption, alcohol dependence, and attributable burden of disease in Europe: Potential gains from effective interventions for alcohol dependence. Toronto, Canada Centre for Addiction and Mental Health: 2012
7. Roerecke M., Rehm J. Alcohol use disorders and mortality: A systematic review and meta-analysis. Addiction: 2013; 108 1562 1578
8. Effertz T., Mann K. The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction. Eur Neuropsychopharmacol: 2013; 23 742 748
9. Alonso J., Angermeyer M. C., Bernert S. et al. Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl: 2004; 109 47 54
10. Cohen E., Feinn R., Arias A. et al. Alcohol treatment utilization: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend: 2007; 86 214 221
11. Hasin D. S., Stinson F. S., Ogburn E. et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Arch Gen Psychiatry: 2007; 64 830 842
12. Kohn R., Saxena S., Levav I. et al. The treatment gap in mental health care. Bull World Health Organ: 2004; 82 858 866
13. Gomes de Matos E., Kraus L., Pabst A. et al. Problembewusstsein und Inanspruchnahme von Hilfe bei substanzbezogenen Problemen. Sucht: 2013; 59 355 366
14. Bloomfield K., Kraus L., Soyka M. Alkoholkonsum und alkoholbezogene Störungen. Berlin Robert Koch-Institut: 2008
15. Regier D. A., Kuhl E. A., Kupfer D. J. The DSM-5: Classification and criteria changes. World Psychiatry: 2013; 12 92 98
16. World Health Organization The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva World Health Organization: 1992
17. Kraus L., Piontek D., Pabst A. et al. Studiendesign und Methodik des Epidemiologischen Suchtsurveys 2012. Sucht: 2013; 59 309 320 Open Access http://www.psycontent.com/content/j3066072t423×578/fulltext.pdf
18. Wittchen H-U, Beloch E., Garczynski E. et al. Münchener Composite International Diagnostic Interview (M-CIDI), Paper-pencil 2.2, 2/95. München Max-Planck-Institut für Psychiatrie, Klinisches Institut: 1995
19. Gesundheitsberichterstattung des Bundes Diagnosedaten der Krankenhäuser ab 2000 (Fälle, Berechnungs- und Belegungstage, durchschnittliche Verweildauer). Online verfügbar unter 2013 http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/WS0100/-XWD-FORMPROC?TARGET=&PAGE=-XWD-356&OPINDEX=9&HANDLER=XS-ROTATE-ADVANCED&DATACUBE=-XWD-384&D.000=ACROSS&D.001=PAGE&D.002=PAGE&D.003=PAGE&D.972=DOWN&D.946=PAGE&D.100=PAGE
20. Gesundheitsberichterstattung des Bundes Mitglieder und mitversicherte Familienangehörige der gesetzlichen Krankenversicherung am 1.7. eines Jahres (Anzahl). Gliederungsmerkmale Jahre, Deutschland, Alter, Geschlecht, Kassenart, Versichertengruppe Online verfügbar unter: 2013; http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/WS0100/-XWD-PROC?-XWD-2/2/XWD-CUBE.DRILL/-XWD-30/D.009/3064 [24. 10. 2013]
21. Verband der privaten Krankenversicherung e.V. Zahlenbericht der privaten Krankenversicherung 2009/2010. Berlin Verband der privaten Krankenversicherung e.V.: 2011
22. Pfeiffer-Gerschel T., Steppan M., Brand H. Deutsche Suchthilfestatistik 2012. Alle Bundesländer. Tabellenband für ambulante Beratungs- und/oder Behandlungsstellen, Fachambulanzen und Institutsambulanzen (Typ 3 und 4). Bezugsgruppe: 10 ZB - irgendeine substanzbezogene HD Abhängigkeit. München IFT Institut für Therapieforschung: 2013
23. Pfeiffer-Gerschel T., Steppan M., Brand H. Deutsche Suchthilfestatistik 2012. Alle Bundesländer. Tabellenband für (teil-)stationäre Rehabilitationseinrichtungen und Adaptionseinrichtungen. Bezugsgruppe: 10 ZB - irgendeine substanzbezogene HD Abhängigkeit. München IFT Institut für Therapieforschung: 2013
24. Statistisches Bundesamt Tiefgegliederte Diagnosedaten der Krankenhauspatientinnen und -patienten 2012. Wiesbaden Statistisches Bundesamt: 2013
25. Lemmens P., Tan E. S., Knibbe R. H. Bias due to nonresponse in a Dutch survey on alcohol consumption. Br J Addict: 1988; 83 1069 1077
26. Fazel S., Bains P., Doll H. Substance abuse and dependence in prisoners: A systematic review. Addiction: 2006; 101 181 191
27. Fazel S., Khosla V., Doll H. et al. The prevalence of mental disorders among the homeless in western countries: Systematic review and meta-regression analysis. PLoS Med: 2008; 5 e225
28. Pabst A., Kraus L., Piontek D. et al. Age differences in diagnostic criteria of DSM-IV alcohol dependence among adults with similar drinking behaviour. Addiction: 2012; 107 331 338
29. Mitchell A. J., Meader N., Bird V. et al. Clinical recognition and recording of alcohol disorders by clinicians in primary and secondary care: Meta-analysis. Br J Psychiatry: 2012; 201 93 100
30. Rumpf H-J, Bohlmann J., Hill A. et al. Physicians' low detection rates of alcohol dependence or abuse: A matter of methodological shortcomings? Br J Psychiatry: 2001; 23 133 137
31. Rehm J., Shield K. D., Rehm M. X. et al. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol: 2013; 23 89 97
32. Rehm J., Roerecke M. Reduction of drinking in problem drinkers and all-cause mortality. Alcohol Alcohol: 2013; 48 509 513
33. Walters G. D. Behavioral self-control training for problem drinkers: A meta-analysis of randomized control studies. Behav Ther: 2000; 31 135 149
34. Roerecke M., Gual A., Rehm J. Reduction of alcohol consumption and subsequent mortality in alcohol use disorders: Systematic review and meta-analyses. J Clin Psychiatry: 2013; 74 e1181 e1189
35. Dawe S., Rees V. W., Mattick R. et al. Efficacy of moderation-oriented cue exposure for problem drinkers: A randomized controlled trial. J Consult Clin Psychol: 2002; 70 1045 1050
36. Heather N., Brodie J., Wale S. et al. A randomized controlled trial of moderation-oriented cue exposure. J Stud Alcohol: 2000; 61 561 570
37. Hester R. K., Delaney H. D., Campbell W. ModerateDrinking.Com and moderation management: Outcomes of a randomized clinical trial with non-dependent problem drinkers. J Consult Clin Psychol: 2011; 79 215 224
38. Riper H., Kramer J., Smit F. et al. Web-based self-help for problem drinkers: A pragmatic randomized trial. Addiction: 2008; 103 218 227
39. Rubio G., Manzanares J., Lopez-Munoz F. et al. Naltrexone improves outcome of a controlled drinking program. J Subst Abuse Treat: 2002; 23 361 366
40. Karhuvaara S., Simojoki K., Virta A. et al. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: A randomized double-blind placebo-controlled multicenter study. Alcohol Clin Exp Res: 2007; 31 1179 1187
41. Mann K., Bladstrom A., Torup L. et al. Extending the treatment options in alcohol dependence: A randomized controlled study of as-needed nalmefene. Biol Psychiatry: 2013; 73 706 713
42. van den Brink W., Aubin H. J., Bladstrom A. et al. Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: Results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol Alcohol: 2013; 48 570 578
43. Rumpf H-J. Frühintervention bei problematischem Alkoholkonsum in der medizinischen Versorgung: Auf dem Weg zur Implementierung. Sucht: 2009; 55 326 327
44. Babor T. F., Caetano R., Casswell S. et al. Alcohol: No ordinary commodity. Oxford Oxford University Press: 2010
45. Holder H. D. Cost benefits of substance abuse treatment: An overview of results from alcohol and drug abuse. J Ment Health Policy Econ: 1998; 1 23 29
46. Holder H. D., Lennox R. D., Blose J. O. The economic benefits of alcoholism treatment: A summary of twenty years of research. Journal of Employee Assistance Research: 1992; 1 63 82
47. Popova S., Mohapatra S., Patra J. et al. A literature review of cost-benefit analyses for the treatment of alcohol dependence. Int J Environ Res Public Health: 2011; 8 3351 3364